Literature DB >> 11732789

Topical mupirocin for eradication of MRSA colonization with mupirocin-resistant strains.

M Semret1, M A Miller.   

Abstract

Topical mupirocin was able to interrupt colonization of 52% and 68% of methicillin-resistant Staphylococcus aureus (MRSA)-colonized patients carrying mupirocin-resistant and -sensitive strains, respectively, including 44.4% and 85.7% of those colonized only in the nares. Although a trend to decreased effectiveness was seen for clearing mupirocin-resistant MRSA, this agent can decolonize many patients with resistant strains.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11732789     DOI： 10.1086/501956

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN： 0899-823X            Impact factor:   3.254


  6 in total

1.  Transient loss of high-level mupirocin resistance in Staphylococcus aureus due to MupA polymorphism.

Authors:  Daniel G Driscoll; Casey L Young; Urs A Ochsner
Journal:  Antimicrob Agents Chemother       Date:  2007-04-16       Impact factor: 5.191

2.  Mode of action and biochemical characterization of REP8839, a novel inhibitor of methionyl-tRNA synthetase.

Authors:  Urs A Ochsner; Casey L Young; Kimberley C Stone; Frank B Dean; Nebojsa Janjic; Ian A Critchley
Journal:  Antimicrob Agents Chemother       Date:  2005-10       Impact factor: 5.191

3.  A double-blind, randomized, controlled trial of topical polysporin triple compound versus topical mupirocin for the eradication of colonization with methicillin-resistant Staphylococcus aureus in a complex continuing care population.

Authors:  S O'Grady; Z Hirji; B Pejcic-Karapetrovic; S Fung; H Dedier; J Takata-Shewchuk; K Zhang; J Conly
Journal:  Can J Infect Dis Med Microbiol       Date:  2009       Impact factor: 2.471

4.  Nasal Carriage of Staphylococcus aureus As a Risk Factor for Skin and Soft Tissue Infections.

Authors:  J. John Weems; Luna B. Beck
Journal:  Curr Infect Dis Rep       Date:  2002-10       Impact factor: 3.725

Review 5.  Retapamulin: a review of its use in the management of impetigo and other uncomplicated superficial skin infections.

Authors:  Lily P H Yang; Susan J Keam
Journal:  Drugs       Date:  2008       Impact factor: 9.546

6.  Mupirocin resistance among methicillin-resistant Staphylococcus aureus-colonized patients at admission to a tertiary care medical center.

Authors:  Tara Babu; Violeta Rekasius; Jorge P Parada; Paul Schreckenberger; Malliswari Challapalli
Journal:  J Clin Microbiol       Date:  2009-05-27       Impact factor: 5.948
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.